For research use only. Not for use in humans.

Ozanezumab (Anti-RTN4 / NOGO)

Synonyms: GSK1223249 Cat.No.A2680

Ozanezumab (Anti-RTN4 / NOGO) is a monoclonal antibody targeting Nogo-A (neurite outgrowth inhibitor A). It can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research. MW :150 KD.

Quality Control

Cited in Nature Medicine for its top-tier quality
SDS
Datasheet

Mechanism of Action

Description	Ozanezumab (Anti-RTN4 / NOGO) is a monoclonal antibody targeting Nogo-A (neurite outgrowth inhibitor A). It can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research. MW :150 KD.
References	[1] https://pubmed.ncbi.nlm.nih.gov/28139349/

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	1310680-64-8
Molecular Weight	150
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100 mM Pro-Ac, 20mM Arg, pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.